Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer's disease drug.

Tomorrows, a global health technology company that connects patients and physicians with pre-approval treatments, today published a new data report, entitled Searching for solutions: How physicians ...

In the Phase III CARES trials, anselamimab did not meet the primary endpoint for advanced-stage AL amyloidosis, but a ...

Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer's disease drug. They found that the drug slowed cognitive decline by 46% in a group of patients ...

A new study by a Tulane University researcher casts doubt on a widely used shortcut in rectal cancer drug trials, raising concerns that some treatments may be fast-tracked for approval without ...

UK & Ireland, experts provided insights on market trends within the clinical trial industry and advice on engagement ...

Patients with rare diseases are increasingly working to find and fund their own cures. But should they have to?

The rate of COVID-related intensive care unit (ICU) admissions was 9.2 per 1,000 person-years among patients who received a monovalent booster and 13.3 per 1,000 person-years for patients who ...

Key Facts. Clinical trials move through four structured phases, from safety testing to long-term effects. Adaptive, basket, and umbrella trials are making cancer research faster and more flexible.

Kimberlin, a professor in the Department of Pediatrics, has decades of experience in clinical trials for rare viral diseases that affect children. “UAB has tremendous clinical research and clinical ...